Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
=========================================================================================================================================================================

* Marijo Bilusic
* Sheri McMahon
* Ravi A Madan
* Fatima Karzai
* Yo-Ting Tsai
* Renee N Donahue
* Claudia Palena
* Caroline Jochems
* Jennifer L Marté
* Charalampos Floudas
* Julius Strauss
* Jason Redman
* Houssein Abdul Sater
* Shahrooz Rabizadeh
* Patrick Soon-Shiong
* Jeffrey Schlom
* James L Gulley